Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?Mebendazole ingredients?Somatuline depot patent expiry date?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?When will generic fiasap insulin be available?
See the DrugPatentWatch profile for Xolair
Xolair is the brand name for omalizumab, marketed by Roche/Genentech. The revenue figure you’re looking for is Roche’s “net sales” for Xolair, which is disclosed in Roche’s annual reports and presentations. To give you a precise number, I need: - Which year you want (e.g., 2023, 2022, etc.) - Whether you want the figure in Swiss francs (CHF) or USD - Global net sales (the standard Roche figure) or a regional breakdown If you’d like, tell me the year and preferred currency and I’ll provide the exact figure from Roche’s financials. If you’re okay with a quick approach, I can also guide you to where to find it in Roche’s annual report.
Other Questions About Xolair :